FDA rejects psychedelic MDMA as treatment for PTSD, calling for additional study

WASHINGTON (AP) — Federal health regulators on Friday declined to approve the psychedelic drug MDMA as a therapy for PTSD, a major setback for groups seeking a breakthrough decision in favor of using mind-altering substances to treat serious mental health conditions. Drugmaker...

FDA won't approve the psychedelic drug MDMA for PTSD, calling for more research on its safety and effectiveness

WASHINGTON (AP) — FDA won't approve the psychedelic drug MDMA for PTSD, calling for more research on its safety and effectiveness.

Veterans lobbied for psychedelic therapy, but it may not be enough to save MDMA drug application

NEW YORK (AP) — It was a landmark moment for the psychedelic movement: The Department of Veteran Affairs’ top doctor stood on stage, praising advocates who have spent decades promoting the healing potential of mind-altering drugs. In an unannounced appearance at a New York...

Veterans have lobbied for MDMA as a potential PTSD treatment, but it may not be enough to save FDA application

WASHINGTON (AP) — Veterans have lobbied for MDMA as a potential PTSD treatment, but it may not be enough to save FDA application.